Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 6/2022

14.07.2022 | Research Article

Risk factors associated with augmented renal clearance in a mixed intensive care unit population: a retrospective study

verfasst von: Emily Bing, Kym Archambault, Alice Sananikone, Kim-Dan Nguyen, Yi Tong Fang, Caren Jabamikos, Cécile Gras, Amélie Marsot, Marc-Alexandre Duceppe, Marc M. Perreault

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 6/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Augmented renal clearance is increasingly recognized in critically ill patients. This condition may lead to suboptimal dosing of renally excreted medications.

Aim

Our primary objective was to identify demographic and clinical factors associated with augmented renal clearance in a mixed critically ill population.

Method

This retrospective single center observational cohort study evaluated patients admitted in a mixed adult intensive care unit for augmented renal clearance, defined as a creatinine clearance of ≥ 130 ml/min/1.73m2, through weekly 24-h urine collection. Variables associated with augmented renal clearance were identified using univariate analysis, then served as covariates in a backward stepwise logistic regression. Goodness-of-fit of the model was assessed and receiver operating characteristic curve was generated.

Results

Augmented renal clearance was observed in 25.3% of the study cohort (n = 324). Age below 50 years (adjusted odds ratio 7.32; 95% CI 4.03–13.29, p < 0.001), lower serum creatinine at intensive care admission (adjusted odds ratio 0.97; 95% CI 0.96–0.99, p < 0.001) and trauma admission (adjusted odds ratio 2.26; 95% CI 1.12–4.54, p = 0.022) were identified as independent risk factors. Our model showed acceptable discrimination in predicting augmented renal clearance (Area under receiver operating characteristic curve (0.810; 95% CI 0.756–0.864, p < 0.001)).

Conclusion

We identified age below 50 years, lower serum creatinine upon intensive care admission and trauma as independent risk factors for augmented renal clearance, consistent with the literature suggesting that patients with low serum creatinine upon admission could have a higher risk of developing augmented renal clearance.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bilbao-Meseguer I, Rodriguez-Gascon A, Barrasa H, et al. Augmented renal clearance in critically Ill patients: a systematic review. Clin Pharmacokinet. 2018;57(9):1107–21.PubMedCrossRef Bilbao-Meseguer I, Rodriguez-Gascon A, Barrasa H, et al. Augmented renal clearance in critically Ill patients: a systematic review. Clin Pharmacokinet. 2018;57(9):1107–21.PubMedCrossRef
2.
3.
Zurück zum Zitat Udy AA, Baptista JP, Lim NL, et al. Augmented renal clearance in the ICU: results of a Multicenter observational study of renal function in critically ill patients with normal plasma Creatinine concentrations. Crit Care Med. 2014;42(3):520–7.PubMedCrossRef Udy AA, Baptista JP, Lim NL, et al. Augmented renal clearance in the ICU: results of a Multicenter observational study of renal function in critically ill patients with normal plasma Creatinine concentrations. Crit Care Med. 2014;42(3):520–7.PubMedCrossRef
4.
Zurück zum Zitat Huttner A, Von Dach E, Renzoni A, et al. Augmented renal clearance, low beta-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study. Int J Antimicrob Agents. 2015;45(4):385–92.PubMedCrossRef Huttner A, Von Dach E, Renzoni A, et al. Augmented renal clearance, low beta-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study. Int J Antimicrob Agents. 2015;45(4):385–92.PubMedCrossRef
5.
Zurück zum Zitat Baptista JP, Roberts JA, Sousa E, et al. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram. Crit Care. 2014;18(1):654.PubMedPubMedCentralCrossRef Baptista JP, Roberts JA, Sousa E, et al. Decreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogram. Crit Care. 2014;18(1):654.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Baptista JP, Martins PJ, Marques M, et al. Prevalence and risk factors for augmented renal clearance in a population of critically Ill patients. J Intensive Care Med. 2020;35(10):1044–52.PubMedCrossRef Baptista JP, Martins PJ, Marques M, et al. Prevalence and risk factors for augmented renal clearance in a population of critically Ill patients. J Intensive Care Med. 2020;35(10):1044–52.PubMedCrossRef
7.
Zurück zum Zitat De Waele JJ, Dumoulin A, Janssen A, et al. Epidemiology of augmented renal clearance in mixed ICU patients. Minerva Anestesiol. 2015;81(10):1079–85.PubMed De Waele JJ, Dumoulin A, Janssen A, et al. Epidemiology of augmented renal clearance in mixed ICU patients. Minerva Anestesiol. 2015;81(10):1079–85.PubMed
8.
Zurück zum Zitat Kawano Y, Maruyama J, Hokama R, et al. Outcomes in patients with infections and augmented renal clearance: a multicenter retrospective study. PLoS ONE. 2018;13(12):e0208742.PubMedPubMedCentralCrossRef Kawano Y, Maruyama J, Hokama R, et al. Outcomes in patients with infections and augmented renal clearance: a multicenter retrospective study. PLoS ONE. 2018;13(12):e0208742.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Barletta JF, Mangram AJ, Byrne M, et al. Identifying augmented renal clearance in trauma patients: validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system. J Trauma Acute Care Surg. 2017;82(4):665–71.PubMedCrossRef Barletta JF, Mangram AJ, Byrne M, et al. Identifying augmented renal clearance in trauma patients: validation of the Augmented Renal Clearance in Trauma Intensive Care scoring system. J Trauma Acute Care Surg. 2017;82(4):665–71.PubMedCrossRef
10.
Zurück zum Zitat Udy AA, Varghese JM, Altukroni M, et al. Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest. 2012;142(1):30–9.PubMedCrossRef Udy AA, Varghese JM, Altukroni M, et al. Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest. 2012;142(1):30–9.PubMedCrossRef
11.
Zurück zum Zitat Baptista JP, Sousa E, Martins PJ, et al. Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents. 2012;39(5):420–3.PubMedCrossRef Baptista JP, Sousa E, Martins PJ, et al. Augmented renal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents. 2012;39(5):420–3.PubMedCrossRef
12.
Zurück zum Zitat Tomasa-Irriguible TM, Sabater-Riera J, Perez-Carrasco M, et al. Augmented renal clearance. An unnoticed relevant event. Sci Prog. 2021;104(2):368504211018580.PubMedCrossRef Tomasa-Irriguible TM, Sabater-Riera J, Perez-Carrasco M, et al. Augmented renal clearance. An unnoticed relevant event. Sci Prog. 2021;104(2):368504211018580.PubMedCrossRef
13.
Zurück zum Zitat Johnston BW, Perry D, Habgood M, et al. Augmented renal clearance: a retrospective, cohort study of urinary creatinine clearance in critically ill patients in the United Kingdom. J Int Med Res. 2021;49(5):3000605211015573.PubMedCrossRef Johnston BW, Perry D, Habgood M, et al. Augmented renal clearance: a retrospective, cohort study of urinary creatinine clearance in critically ill patients in the United Kingdom. J Int Med Res. 2021;49(5):3000605211015573.PubMedCrossRef
14.
Zurück zum Zitat Hobbs ALV, Shea KM, Roberts KM, et al. Implications of augmented renal clearance on drug dosing in critically ill patients: a focus on antibiotics. Pharmacotherapy. 2015;35(11):1063–75.PubMedCrossRef Hobbs ALV, Shea KM, Roberts KM, et al. Implications of augmented renal clearance on drug dosing in critically ill patients: a focus on antibiotics. Pharmacotherapy. 2015;35(11):1063–75.PubMedCrossRef
16.
Zurück zum Zitat Sime FB, Udy AA, Roberts JA. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization. Curr Opin Pharmacol. 2015;24:1–6.PubMedCrossRef Sime FB, Udy AA, Roberts JA. Augmented renal clearance in critically ill patients: etiology, definition and implications for beta-lactam dose optimization. Curr Opin Pharmacol. 2015;24:1–6.PubMedCrossRef
17.
Zurück zum Zitat Udy AA, Putt MT, Boots RJ, et al. ARC–augmented renal clearance. Curr Pharm Biotechnol. 2011;12(12):2020–9.PubMedCrossRef Udy AA, Putt MT, Boots RJ, et al. ARC–augmented renal clearance. Curr Pharm Biotechnol. 2011;12(12):2020–9.PubMedCrossRef
18.
19.
Zurück zum Zitat Udy AA, Roberts JA, Boots RJ, et al. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet. 2010;49(1):1–16.PubMedCrossRef Udy AA, Roberts JA, Boots RJ, et al. Augmented renal clearance: implications for antibacterial dosing in the critically ill. Clin Pharmacokinet. 2010;49(1):1–16.PubMedCrossRef
20.
Zurück zum Zitat Fuster-Lluch O, Gerónimo-Pardo M, Peyró-García R, et al. Glomerular hyperfiltration and albuminuria in critically ill patients. Anaesth Intensive Care. 2008;36(5):674–80.PubMedCrossRef Fuster-Lluch O, Gerónimo-Pardo M, Peyró-García R, et al. Glomerular hyperfiltration and albuminuria in critically ill patients. Anaesth Intensive Care. 2008;36(5):674–80.PubMedCrossRef
21.
Zurück zum Zitat Claus BOM, Hoste EA, Colpaert K, et al. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013;28(5):695–700.PubMedCrossRef Claus BOM, Hoste EA, Colpaert K, et al. Augmented renal clearance is a common finding with worse clinical outcome in critically ill patients receiving antimicrobial therapy. J Crit Care. 2013;28(5):695–700.PubMedCrossRef
22.
Zurück zum Zitat Udy AA, Roberts JA, Shorr AF, et al. Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care. 2013;17(1):R35.PubMedPubMedCentralCrossRef Udy AA, Roberts JA, Shorr AF, et al. Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care. 2013;17(1):R35.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Abdel El Naeem HEM, Abdelhamid MHE, Atteya DAM. Impact of augmented renal clearance on enoxaparin therapy in critically ill patients. Egypt J Anaesth. 2017;33(1):113–7.CrossRef Abdel El Naeem HEM, Abdelhamid MHE, Atteya DAM. Impact of augmented renal clearance on enoxaparin therapy in critically ill patients. Egypt J Anaesth. 2017;33(1):113–7.CrossRef
24.
Zurück zum Zitat Barletta JF, Mangram AJ, Byrne M, et al. The importance of empiric antibiotic dosing in critically ill trauma patients: are we under-dosing based on augmented renal clearance and inaccurate renal clearance estimates? J Trauma Acute Care Surg. 2016;81(6):1115–21.PubMedCrossRef Barletta JF, Mangram AJ, Byrne M, et al. The importance of empiric antibiotic dosing in critically ill trauma patients: are we under-dosing based on augmented renal clearance and inaccurate renal clearance estimates? J Trauma Acute Care Surg. 2016;81(6):1115–21.PubMedCrossRef
25.
Zurück zum Zitat Campassi ML, Gonzalez MC, Masevicius FD, et al. Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment. Rev Bras Ter Intensiva. 2014;26(1):13–20.PubMedPubMedCentralCrossRef Campassi ML, Gonzalez MC, Masevicius FD, et al. Augmented renal clearance in critically ill patients: incidence, associated factors and effects on vancomycin treatment. Rev Bras Ter Intensiva. 2014;26(1):13–20.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Udy A, Boots R, Senthuran S, et al. Augmented creatinine clearance in traumatic brain injury. Anesth Analg. 2010;111(6):1505–10.PubMedCrossRef Udy A, Boots R, Senthuran S, et al. Augmented creatinine clearance in traumatic brain injury. Anesth Analg. 2010;111(6):1505–10.PubMedCrossRef
28.
Zurück zum Zitat May CC, Arora S, Parli SE, et al. Augmented renal clearance in patients with subarachnoid hemorrhage. Neurocrit Care. 2015;23(3):374–9.PubMedCrossRef May CC, Arora S, Parli SE, et al. Augmented renal clearance in patients with subarachnoid hemorrhage. Neurocrit Care. 2015;23(3):374–9.PubMedCrossRef
29.
Zurück zum Zitat Chen IH, Nicolau DP. Augmented renal clearance and how to augment antibiotic dosing. Antibiotics (Basel). 2020;9(7):393.PubMedCrossRef Chen IH, Nicolau DP. Augmented renal clearance and how to augment antibiotic dosing. Antibiotics (Basel). 2020;9(7):393.PubMedCrossRef
30.
Zurück zum Zitat Burnham JP, Micek ST, Kollef MH. Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials. PLoS ONE. 2017;12(7):e0180247.PubMedPubMedCentralCrossRef Burnham JP, Micek ST, Kollef MH. Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials. PLoS ONE. 2017;12(7):e0180247.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Carrie C, Chadefaux G, Sauvage N, et al. Increased beta-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study. Crit Care. 2019;23(1):379.PubMedPubMedCentralCrossRef Carrie C, Chadefaux G, Sauvage N, et al. Increased beta-Lactams dosing regimens improve clinical outcome in critically ill patients with augmented renal clearance treated for a first episode of hospital or ventilator-acquired pneumonia: a before and after study. Crit Care. 2019;23(1):379.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Carlier M, Carrette S, Roberts JA, et al. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Crit Care. 2013;17(3):R84.PubMedPubMedCentralCrossRef Carlier M, Carrette S, Roberts JA, et al. Meropenem and piperacillin/tazobactam prescribing in critically ill patients: does augmented renal clearance affect pharmacokinetic/pharmacodynamic target attainment when extended infusions are used? Crit Care. 2013;17(3):R84.PubMedPubMedCentralCrossRef
33.
Zurück zum Zitat Cucci M, Wooten C, Fowler M, et al. Incidence and risk factors associated with multi-drug–resistant pathogens in a critically Ill trauma population: a retrospective cohort study. Surg Infect (Larchmt). 2020;21(1):15–22.PubMedCrossRef Cucci M, Wooten C, Fowler M, et al. Incidence and risk factors associated with multi-drug–resistant pathogens in a critically Ill trauma population: a retrospective cohort study. Surg Infect (Larchmt). 2020;21(1):15–22.PubMedCrossRef
34.
Zurück zum Zitat Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.PubMedCrossRef Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.PubMedCrossRef
35.
Zurück zum Zitat Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.PubMedPubMedCentralCrossRef Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Upper Saddle River, NJ: Pearson Education; 2013. (ISBN 13: 978-0205849574). Tabachnick BG, Fidell LS. Using multivariate statistics. 6th ed. Upper Saddle River, NJ: Pearson Education; 2013. (ISBN 13: 978-0205849574).
37.
Zurück zum Zitat Minville V, Asehnoune K, Ruiz S, et al. Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study. Crit Care. 2011;15(1):R49.PubMedPubMedCentralCrossRef Minville V, Asehnoune K, Ruiz S, et al. Increased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study. Crit Care. 2011;15(1):R49.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Nazer LH, AbuSara AK, Kamal Y. Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): a prospective observational study evaluating prevalence and risk factors. Pharmacol Res Perspect. 2021;9(2):e00747.PubMedPubMedCentralCrossRef Nazer LH, AbuSara AK, Kamal Y. Augmented renal clearance in critically ill patients with cancer (ARCCAN Study): a prospective observational study evaluating prevalence and risk factors. Pharmacol Res Perspect. 2021;9(2):e00747.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Silva CM, Baptista JP, Santos I, et al. Recommended antibiotic dosage regimens in critically Ill patients with augmented renal clearance: a systematic review. Int J Antimicrob Agents. 2022;59:106569.PubMedCrossRef Silva CM, Baptista JP, Santos I, et al. Recommended antibiotic dosage regimens in critically Ill patients with augmented renal clearance: a systematic review. Int J Antimicrob Agents. 2022;59:106569.PubMedCrossRef
40.
Zurück zum Zitat Xiao Q, Zhang H, Wu X, et al. Augmented renal clearance in severe infections-an important consideration in vancomycin dosing: a narrative review. Front Pharmacol. 2022;13:835557.PubMedPubMedCentralCrossRef Xiao Q, Zhang H, Wu X, et al. Augmented renal clearance in severe infections-an important consideration in vancomycin dosing: a narrative review. Front Pharmacol. 2022;13:835557.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Gijsen M, Huang CY, Flechet M, et al. Development and external validation of an online clinical prediction model for augmented renal clearance in adult mixed critically Ill patients: the augmented renal clearance predictor. Crit Care Med. 2020;48(12):e1260–8.PubMedCrossRef Gijsen M, Huang CY, Flechet M, et al. Development and external validation of an online clinical prediction model for augmented renal clearance in adult mixed critically Ill patients: the augmented renal clearance predictor. Crit Care Med. 2020;48(12):e1260–8.PubMedCrossRef
43.
Zurück zum Zitat Grootaert V, Willems L, Debaveye Y, et al. Augmented renal clearance in the critically ill: how to assess kidney function. Ann Pharmacother. 2012;46(7–8):952–9.PubMedCrossRef Grootaert V, Willems L, Debaveye Y, et al. Augmented renal clearance in the critically ill: how to assess kidney function. Ann Pharmacother. 2012;46(7–8):952–9.PubMedCrossRef
Metadaten
Titel
Risk factors associated with augmented renal clearance in a mixed intensive care unit population: a retrospective study
verfasst von
Emily Bing
Kym Archambault
Alice Sananikone
Kim-Dan Nguyen
Yi Tong Fang
Caren Jabamikos
Cécile Gras
Amélie Marsot
Marc-Alexandre Duceppe
Marc M. Perreault
Publikationsdatum
14.07.2022
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 6/2022
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-022-01458-9

Weitere Artikel der Ausgabe 6/2022

International Journal of Clinical Pharmacy 6/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.